Seizure Detection and Warning System in Epilepsy Patients

Completed

• Conditions: Generalized Tonic-Clonic Seizures; Epilepsy
• Interventions: Device: Brain Sentinel Seizure Detection and Warning System

• Registration Number: NCT02555410
• Lead Sponsor: Brain Sentinel

Brief Summary

This is a phase III, pilot, prospective study of an Electromyography (EMG) based seizure detection system for detecting Generalized Tonic-Clonic Seizures (GTCS) in the home.

Detailed Description

The Brain Sentinel™ Seizure Detection and Warning System is intended for monitoring children and adults with a history or significant risk of generalized tonic-clonic seizures in the home or healthcare facilities, during the titration or withdrawal of anti-epileptic drugs, and for continuous monitoring (night time or any other time of day) of individuals due to their history or risk of generalized tonic-clonic seizures. The device will withstand activities of daily living including showers and sleep.

Study Timeline

• Study Start: 2013-01
• Study First Submitted: 2015-02-13
• Study First Submitted QC: 2015-09-18
• Study First Posted: 2015-09-21
• Status Verified: 2017-07
• Primary Completion: 2017-07-07
• Study Completion: 2017-07-07
• Last Update Submitted: 2017-07-10
• Last Update Posted: 2017-07-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

1. Subject has a history of GTC seizures, either primary GTC or partial onset seizures with secondary generalization.
2. Male or female between the ages of 2-99.
3. Has an upper arm circumference which is adequate for proper fit of the EMG monitor (at least 14cm).
4. Be able to tolerate wearing the device on the upper arm.
5. If female and of childbearing potential, has a negative pregnancy test.
6. Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.
7. Subject and/or Primary Caregiver must be competent to follow all study procedures.
8. Is able to read, speak and understand English.

Exclusion Criteria

1. Does not have a documented history of generalized seizures.
2. The subject's upper arm circumference not adequate for proper fit of the EMG monitor (less than 14cm)
3. Pregnant female
4. Subject/Caregiver is unable to provide consent.
5. Subject/Caregiver is not competent to follow home study procedures.
6. The subject is homeless or in a home without a power supply.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Brain Sentinel Seizure Detection and Warning System	Brain Sentinel Seizure Detection and Warning System	To test the usability of the Brain Sentinel Seizure Detection and Warning System(also known as the SPEAC system) in a patient home setting.

Primary Outcome Measures

Name	Time	Method
Test the function of the system including ability to acquire EMG signal, analyze and successfully transmit the analysis to the base station, and identify and transmit all alert conditions.	up to 1 month	The overall usability and technical features will be assessed through questionnaires and surveys as the Seizure Detection and Warning System will be used within a home setting.

Secondary Outcome Measures

Name	Time	Method
Compare the accuracy of the EMG based system's log to the subject's seizure diary	up to one month	Comparison of the subject's seizure diary to the EMG based seizure detection system's seizure logs will help determine overall function.

Trial Locations

Locations (1)

Jose' E. Cavazos; 🇺🇸 San Antonio, Texas, United States